Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 07, 2016 6:18 AM ET

Healthcare Equipment and Supplies

Company Overview of Bayer HealthCare LLC

Company Overview

Bayer HealthCare LLC develops, manufactures, and markets healthcare and medical products. The company offers blood glucose monitoring systems, diabetes self-care software, and lancing devices; and YAZ, a low-dose oral contraceptive. It also provides diagnostic testing for urinalysis, DCA, immunology, blood gas, and hematology; molecular and clinical chemistry testing to assess and manage health in a myriad of disease states, including cardiovascular, kidney and infectious diseases, oncology, and virology; and Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms, including nausea, phonophobia, and photophobia. The company offers an...

100 Bayer Road

Pittsburgh, PA 15205

United States

Founded in 2002

Phone:

412-777-2000

Fax:

412-777-2447

Key Executives for Bayer HealthCare LLC

President and General Manager, Animal Health Division, North America
President of Animal Health Division for North America and General Manager of Animal Health Division for North America
President of Consumer Care Division
Senior Vice President, Global Head, Product Supply -Biotech and Site Head
Bayer HealthCare Representative U.S.A.
Compensation as of Fiscal Year 2015.

Bayer HealthCare LLC Key Developments

Motley Rice Files Two Suits for California Women against Bayer Corp., Bayer Healthcare LLC, Bayer Essure, Inc., Bayer Healthcare Pharmaceuticals, Inc. and Bayer AG

Motley Rice LLC has filed two suits for California women against Bayer Corp., Bayer Healthcare LLC, Bayer Essure Inc., (formerly known as Conceptus Inc.), Bayer Healthcare Pharmaceuticals Inc., and Bayer AG for personal injuries and 10 alleged counts, including fraudulent concealment and negligent misrepresentation of the permanent birth control device Essure®. Filed in the Superior Court for the State of California County of Santa Clara for Deanna Alonzo of Fillmore, Calif. and Desirea Harvey of Orangevale, Calif., the suits allege that Essure has permanently injured and altered the quality of life of these two young mothers and has left both with no other option than to have a hysterectomy to deal with the complications related to Essure. Essure is a permanent birth control procedure that is a type of tubal sterilization that does not require an incision. During the procedure, a metal spring-like device wound with synthetic fibers is implanted in the fallopian tubes. The metal portion of the device consists of a stainless steel inner coil and an expanding nickel titanium outer coil. The fibers are designed to encourage surrounding tissue to adhere to the device, ultimately creating a barrier of tissue to block sperm from reaching the eggs. Essure was approved by the FDA in 2002, and as of May 2015, there were more than 5,000 reports from both doctors and women to the FDA claiming Essure caused serious side effects, including 11 deaths. Five of those deaths were fetal deaths that occurred in women who became pregnant despite undergoing the Essure procedure.

Bayer Receives FDA Approval for BETACONNECT - Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) approved BETACONNECT, the first and only electronic autoinjector in the treatment of relapsing-remitting multiple sclerosis (RRMS). BETACONNECT will be available exclusively to BETASERON (interferon beta-1b) patients beginning in early 2016. BETASERON is a prescription medicine used to reduce the number of relapses in people with relapsing forms of multiple sclerosis. This includes people who have had their first symptoms of multiple sclerosis and have an MRI consistent with multiple sclerosis. BETASERON will not cure MS but may decrease the number of flare-ups of the disease. After completing the preparation of BETASERON, patients may administer BETASERON by using the BETACONNECT, which should only be used with the syringes provided in the BETASERON packaging.

U.S. Food & Drug Administration Approves Bayer HealthCare's Finacea(R) (azelaic acid) Foam 15% for Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea

Bayer HealthCare announced that the U.S. Food & Drug Administration (FDA) has approved Finacea® (azelaic acid) Foam, 15% for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. Papulopustular rosacea is a skin disease causing inflammatory lesions (papules and pustules) on the nose, cheeks, chin and forehead. Finacea® Foam was developed as part of a research and development collaboration between Foamix Pharmaceuticals Ltd. and Bayer HealthCare, utilizing Foamix's proprietary foam technology platform. According to a license agreement between the two companies, Foamix is entitled to royalties and certain milestone payments upon commercialization of Finacea® Foam.

Similar Private Companies By Industry

Company Name Region
Sonotech, Inc. United States
D & S Dental Laboratory, Inc. United States
Canfield Scientific, Inc. United States
Hymedix, Inc. United States
Implant Direct International, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 17, 2015
Bayer HealthCare, LLC, Bactine
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Bayer HealthCare LLC, please visit www.bayer.us. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.